Volume 51, Issue 4
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Monoclonal antibodies directed against the 260-kD galactose-inhibitable adherence protein (GIAP) of inhibit binding of amebic trophozoites to purified colonic mucins, suggesting that anti-GIAP secretory immunoglobulin A (sIgA) may have a role in host defense in invasive amebiasis. We determined by enzyme-linked immunosorbent assay (ELISA) whether a salivary anti-GIAP sIgA response was present in patients from the Republic of South Africa with invasive infection. In 13 patients with amebic liver abscess (ALA), salivary anti-GIAP sIgA was significantly higher (mean ± SD optical density [OD] = 0.448 ± 0.258) than that determined for seven South African adult patients hospitalized with nonamebic illness (0.084 ± 0.072; = 0.002), seven healthy South African Adults (0.194 ± 0.119; = 0.025), and seven healthy adults from Charlottesville, Virginia (0.036 ± 0.023; = 0.004). Of the patients with ALA, nine had acute disease, and four had been cured of amebiasis 2–8 months previously. There was no significant difference between these two groups in the anti-GIAP sIgA levels. All ALA patients had a high titer serum anti-amebic antibody response, and there was no direct correlation between the level of anti-GIAP salivary IgA and anti-GIAP serum antibodies (R = 0.187). These findings demonstrate that the GIAP is a mucosal antigen in naturally occurring invasive infection.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...


Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error